Patents by Inventor Wolfram Ostertag

Wolfram Ostertag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Retroviral gene transfer vectors
    Patent number: 6548301
    Abstract: The invention relates to novel retroviral gene transfer vectors, preferably expression vectors, which, because of a reduced content of viral genes, are distinguished by a higher safety standard and an expression of non-viral nucleotide sequences in higher amounts.
    Type: Grant
    Filed: May 6, 1999
    Date of Patent: April 15, 2003
    Assignee: Heinrich-Pette-Institut
    Inventors: Wolfram Ostertag, Christopher Baum, Markus Hildinger
  • RETROVIRAL GENE TRANSFER VECTORS
    Publication number: 20020103144
    Abstract: The invention relates to novel retroviral gene transfer vectors, preferably expression vectors, which, because of a reduced content of viral genes, are distinguished by a higher safety standard and an expression of non-viral nucleotide sequences in higher amounts.
    Type: Application
    Filed: May 6, 1999
    Publication date: August 1, 2002
    Inventors: WOLFRAM OSTERTAG, CHRISTOPHER BAUM, MARKUS HILDINGER
  • Retroviral vector hybrids and the use thereof for gene transfer
    Patent number: 5858744
    Abstract: Replication-defective retroviral vector hybrids which are characterized in that they contain a) the U5 region and/or tRNA primer binding site of MESV as the U5 region and/or tRNA primer binding site in the leader region and b) the U3 and R regions from a Friend murine leukaemia virus (F-MuLV) as the U3 and R regions in the 3'-LTR and which are particularly suitable for an effective gene transfer in haematopoietic stem cells.
    Type: Grant
    Filed: March 7, 1997
    Date of Patent: January 12, 1999
    Assignee: Boehringer Mannheim GmbH
    Inventors: Christopher Baum, Carol Stocking-Harbers, Wolfram Ostertag